146 related articles for article (PubMed ID: 8221656)
41. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
44. The prognostic significance of COX-2 and survivin expression in ovarian cancer.
Athanassiadou P; Grapsa D; Athanassiades P; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2008; 204(4):241-9. PubMed ID: 18171606
[TBL] [Abstract][Full Text] [Related]
45. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
46. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
47. Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer.
Yue X; Akahira J; Utsunomiya H; Miki Y; Takahashi N; Niikura H; Ito K; Sasano H; Okamura K; Yaegashi N
Pathol Int; 2010 May; 60(5):400-6. PubMed ID: 20518891
[TBL] [Abstract][Full Text] [Related]
48. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
[TBL] [Abstract][Full Text] [Related]
50. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
[TBL] [Abstract][Full Text] [Related]
51. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
[TBL] [Abstract][Full Text] [Related]
52. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
[TBL] [Abstract][Full Text] [Related]
55. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of IEX-1 expression in ovarian carcinoma.
Han L; Geng L; Liu X; Shi H; He W; Wu MX
Ultrastruct Pathol; 2011 Dec; 35(6):260-6. PubMed ID: 22085302
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptors in ovarian epithelial carcinoma.
Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
[TBL] [Abstract][Full Text] [Related]
58. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.
Bizzi A; Codegoni AM; Landoni F; Marelli G; Marsoni S; Spina AM; Torri W; Mangioni C
Cancer Res; 1988 Nov; 48(21):6222-6. PubMed ID: 3167868
[TBL] [Abstract][Full Text] [Related]
59. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays.
Press MF; Holt JA; Herbst AL; Greene GL
Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069
[TBL] [Abstract][Full Text] [Related]
60. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
